| Brayden Paul Yellman, MD | |
|
181 E Medical Tower Dr, Murray, UT 84107-8538 | |
| (801) 314-7800 | |
| Not Available |
| Full Name | Brayden Paul Yellman |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 13 Years |
| Location | 181 E Medical Tower Dr, Murray, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194011841 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 9878247-1205 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bateman Horne Center Of Excellence Inc | 7618287731 | 3 |
News Archive
Unilife Corporation today announced it has received from the U.S. Food and Drug Administration 510(k) market clearance for the Unitract™ 1mL Insulin Syringes assembled at its Lewisberry, PA manufacturing facility.
The nature of mania symptoms appears to be similar in young people with bipolar disorder, irrespective of whether they occur in childhood or adolescence, say researchers.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the Southern District of Indiana has issued a decision invalidating two patents listed in the FDA's Orange Book for Eli Lilly's Evista® (raloxifene hydrochloride) Tablets in litigation concerning Teva's abbreviated new drug application to market a generic version. The court found these patents to be invalid for lack of written description.
The findings of a large international prospective study published in the Journal of Clinical Oncology suggest for the first time that women with BRCA1 mutations should have preventive ovarian surgery (prophylactic oophorectomy) by age 35, as waiting until a later age appears to increase the risk of ovarian cancer before or at the time of the preventive surgery.
› Verified 6 days ago
| Entity Name | Bateman Horne Center Of Excellence Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578931879 PECOS PAC ID: 7618287731 Enrollment ID: O20151102001798 |
News Archive
Unilife Corporation today announced it has received from the U.S. Food and Drug Administration 510(k) market clearance for the Unitract™ 1mL Insulin Syringes assembled at its Lewisberry, PA manufacturing facility.
The nature of mania symptoms appears to be similar in young people with bipolar disorder, irrespective of whether they occur in childhood or adolescence, say researchers.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the Southern District of Indiana has issued a decision invalidating two patents listed in the FDA's Orange Book for Eli Lilly's Evista® (raloxifene hydrochloride) Tablets in litigation concerning Teva's abbreviated new drug application to market a generic version. The court found these patents to be invalid for lack of written description.
The findings of a large international prospective study published in the Journal of Clinical Oncology suggest for the first time that women with BRCA1 mutations should have preventive ovarian surgery (prophylactic oophorectomy) by age 35, as waiting until a later age appears to increase the risk of ovarian cancer before or at the time of the preventive surgery.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brayden Paul Yellman, MD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (801) 314-7800 | Brayden Paul Yellman, MD 181 E Medical Tower Dr, Murray, UT 84107-8538 Ph: (801) 314-7800 |
News Archive
Unilife Corporation today announced it has received from the U.S. Food and Drug Administration 510(k) market clearance for the Unitract™ 1mL Insulin Syringes assembled at its Lewisberry, PA manufacturing facility.
The nature of mania symptoms appears to be similar in young people with bipolar disorder, irrespective of whether they occur in childhood or adolescence, say researchers.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the Southern District of Indiana has issued a decision invalidating two patents listed in the FDA's Orange Book for Eli Lilly's Evista® (raloxifene hydrochloride) Tablets in litigation concerning Teva's abbreviated new drug application to market a generic version. The court found these patents to be invalid for lack of written description.
The findings of a large international prospective study published in the Journal of Clinical Oncology suggest for the first time that women with BRCA1 mutations should have preventive ovarian surgery (prophylactic oophorectomy) by age 35, as waiting until a later age appears to increase the risk of ovarian cancer before or at the time of the preventive surgery.
› Verified 6 days ago
Bogdan Ciprian Anea, MD Rheumatology Medicare: Medicare Enrolled Practice Location: Intermountain Kidney Services Clinic, 5169 South Cottonwood Street, Suite 320, Murray, UT 84107 Phone: 801-507-2531 Fax: 801-507-2597 | |
E Dennis Genebach, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 5801 Fashion Blvd, Murray, UT 84107 Phone: 801-314-4544 | |
Dr. Samuel Morris Brown, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5121 S Cottonwood St, Murray, UT 84107 Phone: 801-507-6415 | |
Dr. Jamie Lynn Rebman, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5121 Cottonwood Rd, Suite 610, Murray, UT 84107 Phone: 801-507-3630 Fax: 801-507-3630 | |
Dr. Kia Afshar, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5169 S Cottonwood St Ste 520, Murray, UT 84107 Phone: 801-507-4701 | |
Rachel Elizabeth Hu, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5171 S Cottonwood St Ste 610, Murray, UT 84107 Phone: 801-507-3900 Fax: 801-507-3640 | |
Caroline Nebhan, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5171 S Cottonwood St Ste 610, Murray, UT 84107 Phone: 801-507-3630 |